Literature DB >> 31536039

Trisomy 13 mosaicism.

Francisco Cammarata-Scalisi1, Dianora Araque1, Rosmary Ramírez2, Luis Guaran3, Gloria Da Silva1.   

Abstract

Background: Trisomy 13 is a chromosomal alteration with an incidence of 1 in 10,000 to 20,000 births. It can occur completely, partially or in mosaicism; the latter occurs when a percentage of cells are trisomic for chromosome 13, while the rest are euploid in an individual and corresponds to only 5% of all cases. Patients with trisomy 13 present a wide variable expressivity, ranging from severe malformations with early death (phenotype similar to the complete form and more frequent), to normal development and few dysmorphic findings. Case reports: The clinical and cytogenetic findings of two new cases of trisomy 13 mosaicism are described. Conclusions: The importance of prenatal diagnosis, clinical findings, and interdisciplinary medical evaluation is highlighted, as well as an appropriate genetic counseling. Copyright:
© 2019 Permanyer.

Entities:  

Keywords:  Asesoramiento genético; Clinical; Clínica; Diagnóstico prenatal; Genetic counseling; Mosaicism; Mosaicismo; Prenatal diagnosis; Trisomy 13; Trisomía 13

Mesh:

Year:  2019        PMID: 31536039     DOI: 10.24875/BMHIM.19000003

Source DB:  PubMed          Journal:  Bol Med Hosp Infant Mex        ISSN: 0539-6115


  2 in total

1.  COVID-19 in a mosaic trisomy 13 patient with polycystic kidney disease.

Authors:  Natalie K Ost; Heather M Minchew; Andrew Garcia; Hammad A Ganatra
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17

2.  Mosaic proximal trisomy 13q and regular trisomy 13 in a female patient with long survival: Involvement of an incomplete trisomic rescue and a chromothripsis event.

Authors:  Verónica Fabiola Morán-Barroso; Alicia Cervantes; María Del Refugio Rivera-Vega; Adriana Del Castillo-Moreno; Alejandra Moreno-Chacón; Estefanía Mejía-Cauich; Laura Eréndira Contreras-Ortiz; Fernando Fernández-Ramírez
Journal:  Mol Genet Genomic Med       Date:  2021-07-20       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.